Harbour Investments’s MacroGenics MGNX Stock Holding History

Harbour Investments’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3	Closed	–	–	3268
2021 Q3	$0	Buy	3 +1	+50%	+$24	﹤0.01%	3882
2021 Q2	$0	Hold	2	–	–	﹤0.01%	3880
2021 Q1	$0	Buy	+2	New	+$49	﹤0.01%	3671

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Harbour Investments's MGNX Position: Q4 2021 in Review

Harbour Investments sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 3 shares.

Harbour Investments first reported a position in MGNX in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

Harbour Investments reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 3 MacroGenics shares in Q4 2021.
Harbour Investments first reported a position in MacroGenics in Q1 2021 and held it in 3 quarters.
Harbour Investments's MacroGenics position peaked at $0 in Q3 2021.
156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.